DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-beta/SMAD4 signaling

Chan, DW; Hui, WWY; Wang, JJ; Yung, MMH; Hui, LMN; Qin, Y; Liang, RR; Leung, THY; Xu, D; Chan, KKL; Yao, KM; Tsang, BK; Ngan, HYS

Chan, DW (reprint author), Univ Hong Kong, Dept Obstet & Gynaecol, LKS Fac Med, L747 Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.

ONCOGENE, 2017; 36 (10): 1404